-DOCSTART- -X- O
Increasing -X- _ O
the -X- _ O
intracellular -X- _ B-Intervention
Zn -X- _ I-Intervention
( -X- _ I-Intervention
2+ -X- _ I-Intervention
) -X- _ I-Intervention
concentration -X- _ I-Intervention
with -X- _ I-Intervention
zinc-ionophores -X- _ I-Intervention
like -X- _ O
pyrithione -X- _ O
( -X- _ O
PT -X- _ O
) -X- _ O
can -X- _ O
efficiently -X- _ O
impair -X- _ O
the -X- _ O
replication -X- _ O
of -X- _ O
a -X- _ O
variety -X- _ O
of -X- _ O
RNA -X- _ O
viruses -X- _ O
, -X- _ O
including -X- _ O
poliovirus -X- _ O
and -X- _ O
influenza -X- _ O
virus. -X- _ O
For -X- _ O
some -X- _ O
viruses -X- _ O
this -X- _ O
effect -X- _ O
has -X- _ O
been -X- _ O
attributed -X- _ O
to -X- _ O
interference -X- _ O
with -X- _ O
viral -X- _ O
polyprotein -X- _ O
processing. -X- _ O
In -X- _ O
this -X- _ O
study -X- _ O
we -X- _ O
demonstrate -X- _ O
that -X- _ O
the -X- _ O
combination -X- _ B-Intervention
of -X- _ I-Intervention
Zn -X- _ I-Intervention
( -X- _ I-Intervention
2+ -X- _ I-Intervention
) -X- _ I-Intervention
and -X- _ I-Intervention
PT -X- _ I-Intervention
at -X- _ I-Intervention
low -X- _ I-Intervention
concentrations -X- _ I-Intervention
( -X- _ I-Intervention
2 -X- _ I-Intervention
μM -X- _ I-Intervention
Zn -X- _ I-Intervention
( -X- _ I-Intervention
2+ -X- _ I-Intervention
) -X- _ I-Intervention
and -X- _ I-Intervention
2 -X- _ I-Intervention
μM -X- _ I-Intervention
PT -X- _ I-Intervention
) -X- _ I-Intervention
inhibits -X- _ B-Outcome
the -X- _ I-Outcome
replication -X- _ I-Outcome
of -X- _ O
SARS-coronavirus -X- _ B-Patient
( -X- _ I-Patient
SARS- -X- _ I-Patient
CoV -X- _ I-Patient
) -X- _ I-Patient
and -X- _ I-Patient
equine -X- _ I-Patient
arteritis -X- _ I-Patient
virus -X- _ I-Patient
( -X- _ I-Patient
EAV -X- _ I-Patient
) -X- _ I-Patient
in -X- _ O
cell -X- _ O
culture. -X- _ O
The -X- _ O
RNA -X- _ O
synthesis -X- _ O
of -X- _ O
these -X- _ O
two -X- _ O
distantly -X- _ O
related -X- _ O
nidoviruses -X- _ O
is -X- _ O
catalyzed -X- _ O
by -X- _ O
an -X- _ O
RNA-dependent -X- _ O
RNA -X- _ O
polymerase -X- _ O
( -X- _ O
RdRp -X- _ O
) -X- _ O
, -X- _ O
which -X- _ O
is -X- _ O
the -X- _ O
core -X- _ O
enzyme -X- _ O
of -X- _ O
their -X- _ O
multiprotein -X- _ O
replication -X- _ O
and -X- _ O
transcription -X- _ O
complex -X- _ O
( -X- _ O
RTC -X- _ O
) -X- _ O
. -X- _ O
Using -X- _ O
an -X- _ O
activity -X- _ O
assay -X- _ O
for -X- _ O
RTCs -X- _ O
isolated -X- _ O
from -X- _ O
cells -X- _ O
infected -X- _ O
with -X- _ O
SARS-CoV -X- _ O
or -X- _ O
EAV—thus -X- _ O
eliminating -X- _ O
the -X- _ O
need -X- _ O
for -X- _ O
PT -X- _ O
to -X- _ O
transport -X- _ O
Zn -X- _ O
( -X- _ O
2+ -X- _ O
) -X- _ O
across -X- _ O
the -X- _ O
plasma -X- _ O
membrane—we -X- _ O
show -X- _ O
that -X- _ O
Zn -X- _ B-Outcome
( -X- _ I-Outcome
2+ -X- _ I-Outcome
) -X- _ I-Outcome
efficiently -X- _ I-Outcome
inhibits -X- _ I-Outcome
the -X- _ I-Outcome
RNA- -X- _ I-Outcome
synthesizing -X- _ I-Outcome
activity -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
RTCs -X- _ I-Outcome
of -X- _ I-Outcome
both -X- _ I-Outcome
viruses. -X- _ I-Outcome
Enzymatic -X- _ I-Outcome
studies -X- _ I-Outcome
using -X- _ I-Outcome
recombinant -X- _ I-Outcome
RdRps -X- _ I-Outcome
( -X- _ I-Outcome
SARS-CoV -X- _ I-Outcome
nsp12 -X- _ I-Outcome
and -X- _ I-Outcome
EAV -X- _ I-Outcome
nsp9 -X- _ I-Outcome
) -X- _ I-Outcome
purified -X- _ I-Outcome
from -X- _ I-Outcome
E. -X- _ I-Outcome
coli -X- _ I-Outcome
subsequently -X- _ I-Outcome
revealed -X- _ I-Outcome
that -X- _ I-Outcome
Zn -X- _ I-Outcome
( -X- _ I-Outcome
2+ -X- _ I-Outcome
) -X- _ I-Outcome
directly -X- _ I-Outcome
inhibited -X- _ I-Outcome
the -X- _ I-Outcome
in -X- _ I-Outcome
vitro -X- _ I-Outcome
activity -X- _ I-Outcome
of -X- _ I-Outcome
both -X- _ I-Outcome
nidovirus -X- _ I-Outcome
polymerases. -X- _ I-Outcome
More -X- _ I-Outcome
specifically -X- _ I-Outcome
, -X- _ I-Outcome
Zn -X- _ I-Outcome
( -X- _ I-Outcome
2+ -X- _ I-Outcome
) -X- _ I-Outcome
was -X- _ I-Outcome
found -X- _ I-Outcome
to -X- _ I-Outcome
block -X- _ I-Outcome
the -X- _ I-Outcome
initiation -X- _ I-Outcome
step -X- _ I-Outcome
of -X- _ I-Outcome
EAV -X- _ I-Outcome
RNA -X- _ I-Outcome
synthesis -X- _ I-Outcome
, -X- _ I-Outcome
whereas -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
case -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
SARS-CoV -X- _ I-Outcome
RdRp -X- _ I-Outcome
elongation -X- _ I-Outcome
was -X- _ I-Outcome
inhibited -X- _ I-Outcome
and -X- _ I-Outcome
template -X- _ I-Outcome
binding -X- _ I-Outcome
reduced. -X- _ I-Outcome
By -X- _ O
chelating -X- _ O
Zn -X- _ O
( -X- _ O
2+ -X- _ O
) -X- _ O
with -X- _ O
MgEDTA -X- _ O
, -X- _ O
the -X- _ O
inhibitory -X- _ O
effect -X- _ O
of -X- _ O
the -X- _ O
divalent -X- _ O
cation -X- _ O
could -X- _ O
be -X- _ O
reversed -X- _ O
, -X- _ O
which -X- _ O
provides -X- _ O
a -X- _ O
novel -X- _ O
experimental -X- _ O
tool -X- _ O
for -X- _ O
in -X- _ O
vitro -X- _ O
studies -X- _ O
of -X- _ O
the -X- _ O
molecular -X- _ O
details -X- _ O
of -X- _ O
nidovirus -X- _ O
replication -X- _ O
and -X- _ O
transcription -X- _ O
. -X- _ O

